Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population
The FASEB Journal · 2025
DOI: 10.1096/fj.202403009r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von L M Echeverry-Quiceno und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals (BEECA), Facultat de Biologia, Universitat de Barcelona (UB), Barcelona, Spain. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Sleep Apnea, Obstructive, Face. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation Jérôme Lejeune, Generalitat de Catalunya, MEC | Instituto de Salud Carlos III (ISCIII).
Themen: Demenz
Abstract (Originalsprache)
Down syndrome (DS), caused by trisomy 21, is associated with an increased risk of Alzheimer's disease (AD) and obstructive sleep apnea (OSA). Traditional diagnostic methods for AD and OSA, like cerebrospinal fluid analysis and polysomnography, are invasive and challenging for people with DS. In this study, we assessed whether facial morphology could be used as a potential noninvasive biomarker for these conditions in both DS and the general population. We performed a comprehensive 3D analysis of facial shape variation by registering the 3D coordinates of 21 landmarks on facial models extracted from magnetic resonance images of 131 individuals with DS and 216 euploid (EU) adult controls, including AD and OSA cases. Procrustes ANOVA and MANOVA quantified shape variation by sex, age, and facial size, while geometric morphometrics assessed diagnostic group differences. Significant facial shape differences were observed between the DS and EU groups, indicating sex‐dependent differences and altered age‐related changes in DS, particularly in females. Facial shape correlated with the amyloid beta ratio (Aβ1‐42/Aβ1‐40), a key AD biomarker. In DS, facial shape differences by AD diagnosis were not significant after adjusting for age and facial size, but significant shape differences were detected in the EU population. For OSA, facial shape correlated with the apnea–hypopnea index (AHI), and DS individuals with severe OSA showed distinct facial morphology compared with those without OSA, suggesting an association between facial shape and sleep respiratory disturbances. These results highlight the potential of facial morphology as a noninvasive biomarker for AD and OSA detection and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals (BEECA), Facultat de Biologia, Universitat de Barcelona (UB), Barcelona, Spain.
- HER - Human-Environment Research Group, La Salle - Universitat Ramon Llull, Barcelona, Spain.
- Multidisciplinary Sleep Unit - Respiratory Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Institut de Recerca Sant Pau -, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Memory Unit, Department of Neurology, Institut de Recerca Sant Pau - Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Madrid, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
- Neuroradiology Section, Department of Radiology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
ORCID-Profile: L M Echeverry-Quiceno, S Llambrich, Á Heredia-Lidón, S Giménez, M Rozalem-Aranha, P Inampudi, Y Heuzé, X Sevillano, J Fortea, N Martínez-Abadías
Förderung
- Fondation Jérôme Lejeune
- Generalitat de Catalunya
- MEC | Instituto de Salud Carlos III (ISCIII)
- HHS | National Institutes of Health (NIH)
- Alzheimer's Association (AA) and Global Brain Health Institute (GBHI)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)
- MEC | Agencia Española de Investigación (AEI)
- Fundación Álvaro Entrecanales-Lejeune
Zitieren
APA
Echeverry-Quiceno, L. M., Llambrich, S., Heredia-Lidón, Á., Giménez, S., Rozalem-Aranha, M., Inampudi, P., Heuzé, Y., Sevillano, X., Fortea, J., Martínez-Abadías, N., & Alzheimer's Disease Neuroimaging Initiative (2025). Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population. The FASEB Journal. https://doi.org/10.1096/fj.202403009r
Vancouver
Echeverry-Quiceno LM, Llambrich S, Heredia-Lidón Á, Giménez S, Rozalem-Aranha M, Inampudi P, et al. Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population. The FASEB Journal. 2025. doi:10.1096/fj.202403009r
BibTeX
@article{EcheverryQuiceno2025,
author = {Echeverry-Quiceno, L M and Llambrich, S and Heredia-Lidón, Á and Giménez, S and Rozalem-Aranha, M and Inampudi, P and Heuzé, Y and Sevillano, X and Fortea, J and Martínez-Abadías, N and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403009r}
}
EUVIMED